前收市價 | 74.19 |
開市 | 75.57 |
買盤 | 74.70 x 200 |
賣出價 | 74.86 x 200 |
今日波幅 | 74.36 - 76.32 |
52 週波幅 | 55.02 - 98.40 |
成交量 | |
平均成交量 | 723,995 |
市值 | 3.552B |
Beta 值 (5 年,每月) | 1.10 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -5.27 |
業績公佈日 | 2024年5月06日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 120.73 |
Axsome Therapeutics (AXSM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
In this article, we will be taking a look at the 15 most black states in the US. If you do not want to learn about the demographics of global black population, head straight to the 5 Most Black States in the US. Overview of the Global Black Population: Demographics, Trends, and Immigration Patterns The […]
Axsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol for the treatment of binge eating disorder in adults.